Amy L. Gryshuk

GryshukPhotoDr. Amy L. Gryshuk received her Bachelor of Science degree in Chemistry at Saint Francis University in Loretto, PA in 2000.  She subsequently joined the Department of Molecular Pharmacology & Cancer Therapeutics at Roswell Park Cancer Institute – a Division of The State University of New York at Buffalo as a predoctoral student from 2000-2005.  From 2003-2005 she received an Integrated Graduate Education Research Traineeship in Biophotonics.  Her doctoral thesis analyzed fluorinated and non-fluorinated photosensitizers as potential ‘bi-functional’ agents for the diagnosis and treatment of cancer via photodynamic therapy.  This work has led to numerous publications in scientific texts and peer-reviewed journals.  With successful completion of her thesis in 2005, Amy accepted a position as a postdoctoral researcher with the University of California, Davis – Center for Biophotonics from 2005 to 2006.  During the first year of her postdoctoral position she designed and evaluated novel bioluminescent substrates for bioluminescence-based protease assays.  This was a highly collaborative project between CBST, Stanford University and Lawrence Livermore National Laboratory (LLNL).  From 2006 to 2008, she transferred into the Chemistry, Materials, Earth and Life Sciences – Biosciences & Biotechnology Division at LLNL continuing on the medical biophotonics CBST-funded project, as well as integrating into a short-lived bio-security project at LLNL.

Following completion of her postdoctoral position in August 2008, Dr. Gryshuk joined CBST in September 2008 as a University of California, Davis Discovery Fellow funded by the Industry-University Cooperative Research Program.  As the Director of New Ventures (DNV) she will use her scientific expertise and co-inventor status on two submitted patents to evaluate measures for developing a viable sustainability model for our National Science Foundation sponsored Center of Excellence in Biophotonics.  Her focus is on the ever increasing need for establishing a viable model for translating university-based research to product opportunities that could impact the practice of clinical medicine.